Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

Author： Lee S.A. Orque R. Escarpe P.A. Peterson M.L. Good J.W. Zaharias E.M. Berman P.W. Sheppard H.W. Shibata R.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.3, 2001-11, pp. : 563-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

By NIAID AIDS Gorse G.J. Rogers J.H. Perry J.E. Newman F.K. Frey S.E. Patel G.B. Belshe R.B.

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 209-214

Elsevier

Access to resources Recommend Favorite

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A. Honnen W.J. Kayman S.C. Trochev O. Wu Z.

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite

HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates

By Davis D.

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 353-354

Elsevier

Access to resources Recommend Favorite

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M. Scheiermann N.

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases

By Donners H. Vermoesen T. Willems B. Davis D. van der Groen G.

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 104-111

Elsevier

Access to resources Recommend Favorite